
  
    
      
        Introduction_NNP
        Rheumatoid_NNP arthritis_NN (_( RA_NNP )_) is_VBZ characterized_VBN by_IN synovial_NN
        tissue_NN leukocyte_NN infiltration_NN and_CC angiogenesis_NNS [_NN 1_CD ]_NN ._. The_DT
        neovascularization_NN process_NN in_IN RA_NNP is_VBZ dependent_JJ on_IN the_DT
        balance_NN between_IN angiogenic_JJ mediators_NNS and_CC inhibitors_NNS ._. The_DT
        angiogenic_JJ mediators_NNS include_VBP growth_NN factors_NNS ,_, cytokines_NNS ,_,
        chemokines_NNS ,_, adhesion_NN receptors_NNS and_CC proteolytic_JJ enzymes_NNS [_NN 2_CD
        ]_NN ._. These_DT factors_NNS ,_, which_WDT are_VBP released_VBN by_IN endothelial_NN cells_NNS
        and_CC macrophages_NNS ,_, have_VBP been_VBN shown_VBN to_TO play_VB an_DT important_JJ role_NN
        in_IN the_DT pathogenesis_NNS of_IN RA_NNP [_NN 2_CD ]_NN ._.
        Tie_NNP receptors_NNS constitute_VBP a_DT family_NN of_IN endothelial_NN
        tyrosine_NN kinase_NN receptors_NNS [_NN 3_CD 4_CD ]_NN ._. There_EX are_VBP two_CD members_NNS
        in_IN this_DT receptor_NN family_NN ,_, termed_VBD Tie_NNP 1_CD and_CC Tie_NNP 2_CD (_( also_RB known_VBN
        as_IN Tek_NNP )_) ._. Tie_NNP 1_CD is_VBZ an_DT orphan_JJ receptor_NN ,_, whereas_IN the_DT ligands_NNS of_IN
        Tie_NNP 2_CD receptor_NN have_VBP been_VBN identified_VBN as_IN angiopoietin_NN (_( Ang_NNP )_) -_: 1_CD
        and_CC Ang-_NNP 2_CD [_NN 5_CD 6_CD ]_NN ._. Ang-_NNP 1_CD has_VBZ been_VBN shown_VBN to_TO be_VB responsible_JJ
        for_IN recruiting_VBG and_CC sustaining_VBG periendothelial_NN support_NN cells_NNS
        [_NN 7_CD ]_NN ._. It_PRP has_VBZ been_VBN reported_VBN that_IN Ang-_NNP 2_CD disrupts_NNS blood_NN
        vessel_NN formation_NN in_IN the_DT developing_VBG embryo_NN by_IN antagonizing_VBG
        Ang-_NNP 1_CD -_: induced_VBN autophosphorylation_NN of_IN Tie_NNP 2_CD [_NN 6_CD ]_NN ._.
        Transgenic_NNP mouse_NN models_NNS of_IN Tie_NNP 2_CD /_NN Ang-_NNP 1_CD result_NN in_IN embryonic_JJ
        lethality_NN due_JJ to_TO absence_NN of_IN remodeling_VBG and_CC sprouting_VBG of_IN
        blood_NN vessels_NNS [_NN 7_CD 8_CD ]_NN ._. The_DT physiologic_JJ roles_NNS of_IN the_DT Tie_NNP 2_CD
        receptor_NN and_CC its_PRP$ ligands_NNS are_VBP limited_VBN to_TO angiogenic_JJ
        processes_NNS that_WDT occur_VBP subsequently_RB to_TO the_DT earlier_JJR
        vasculogenic_JJ and_CC angiogenic_JJ actions_NNS of_IN vascular_NN endothelial_NN
        growth_NN factor_NN (_( VEGF_NNP )_) and_CC its_PRP$ receptors_NNS [_NN 7_CD ]_NN ._. VEGF_NNP and_CC the_DT
        Tie_NNP family_NN orchestrate_NN optimal_NN blood_NN vessel_NN formation_NN [_NN 9_CD
        10_CD ]_NN ._.
        Little_NNP is_VBZ known_VBN about_IN the_DT role_NN of_IN Tie_NNP receptors_NNS and_CC the_DT
        ligands_NNS Ang-_NNP 1_CD and_CC Ang-_NNP 2_CD in_IN RA_NNP synovial_NN tissue_NN ._. To_TO determine_VB
        which_WDT of_IN these_DT angiogenic_JJ factors_NNS may_MD play_VB a_DT role_NN in_IN RA_NNP ,_, we_PRP
        investigated_VBD both_DT the_DT distribution_NN and_CC the_DT levels_NNS of_IN mRNA_NN
        for_IN Tie_NNP 1_CD ,_, Tie_NNP 2_CD ,_, Ang-_NNP 1_CD and_CC Ang-_NNP 2_CD in_IN synovial_NN tissue_NN obtained_VBN
        from_IN RA_NNP patients_NNS ,_, compared_VBN with_IN that_DT from_IN subjects_NNS with_IN
        osteoarthritis_NNS (_( OA_NNP )_) and_CC normal_JJ tissues_NNS ._.
      
      
        Materials_NNS and_CC methods_NNS
        
          Antibodies_NNP and_CC immunohistochemistry_NN
          Synovial_NNP tissues_NNS (_( 4_CD μm_NN )_) were_VBD fixed_VBN in_IN cold_JJ acetone_NN for_IN
          20_CD minutes_NNS ._. Endogenous_NNP peroxidase_NN was_VBD quenched_JJ by_IN
          treatment_NN with_IN 3_CD %_NN H_NNP 
          2_CD O_NNP 
          2_CD for_IN 5_CD minutes_NNS ._. Synovial_NNP tissues_NNS were_VBD
          pretreated_JJ with_IN either_DT 3_CD %_NN horse_NN or_CC goat_NN serum_NN for_IN one_CD
          hour_NN at_IN 37_CD °_NN C_NNP before_IN application_NN of_IN primary_JJ antibody_NN ._.
          Indirect_JJ immunoperoxidase_NN staining_VBG was_VBD performed_VBN at_IN 37_CD °_NN C_NNP
          for_IN one_CD hour_NN using_VBG Vector_NNP Elite_NNP ABC_NNP kits_NNS (_( Vector_NNP ,_,
          Burlingame_NNP ,_, CA_NNP ,_, USA_NNP )_) and_CC diaminobenzidine_NN (_( Kirkegaard_NNP and_CC
          Perry_NNP ,_, Gaitherburg_NNP ,_, MD_NNP ,_, USA_NNP )_) as_IN a_DT chromogen_NN [_NN 11_CD 12_CD ]_NN ._.
          The_DT polyclonal_NN antibodies_NNS ,_, goat_NN antihuman_NN Ang-_NNP 1_CD and_CC
          Ang-_NNP 2_CD ,_, and_CC rabbit_NN antihuman_NN Tie_NNP 1_CD and_CC Tie_NNP 2_CD ,_, were_VBD purchased_VBN
          from_IN Santa_NNP Cruz_NNP Biotechnology_NNP (_( Santa_NNP Cruz_NNP ,_, CA_NNP ,_, USA_NNP )_) ._.
          Additionally_RB ,_, goat_NN antihuman_NN Tie_NNP 1_CD and_CC Tie_NNP 2_CD antibodies_NNS
          were_VBD purchased_VBN from_IN R_NN &_CC D_NNP Systems_NNPS (_( Minneapolis_NNP ,_, MN_NNP ,_,
          USA_NNP )_) ._. Antibodies_NNP did_VBD not_RB cross-react_JJ with_IN other_JJ members_NNS
          of_IN the_DT Tie_NNP family_NN ._.
          Macrophage_NNP identity_NN was_VBD confirmed_VBN by_IN reactivity_NN of_IN
          cells_NNS with_IN the_DT mouse_NN antihuman_NN mAb_NN ,_, CD_NNP 11_CD c_SYM (_( Becton_NNP
          Dickinson_NNP ,_, Mountain_NNP View_NNP ,_, CA_NNP ,_, USA_NNP )_) ._. Rabbit_NNP antihuman_NN von_NNP
          Willebrand_NNP factor_NN (_( Dako_NNP ,_, Carpinteria_NNP ,_, CA_NNP ,_, USA_NNP )_) was_VBD used_VBN
          to_TO identify_VB endothelium_NN ._. Isotype-specific_NNP IgG_NNP was_VBD used_VBN as_IN
          a_DT negative_JJ control_NN ._.
        
        
          Cell_NNP culture_NN ,_, RNA_NNP quantification_NN and_CC western_JJ blot_NN
          analysis_NN
          Cell_NNP culture_NN ,_, RNA_NNP purification_NN ,_, reverse_VB transcription_NN ,_,
          standard_JJ dilution_NN preparation_NN ,_, real-time_JJ reverse_NN
          transcription_NN polymerase_NN chain_NN reaction_NN (_( RT-PCR_NNP )_)
          quantification_NN (_( TaqMan_NNP )_) and_CC western_JJ blot_NN analysis_NN are_VBP
          detailed_JJ in_IN the_DT supplementary_JJ material_NN ._.
        
      
      
        Results_NNS
        
          Ang-_NNP 1_CD
          Ang-_NNP 1_CD ,_, was_VBD expressed_VBN on_IN synovial_NN lining_NN cells_NNS in_IN RA_NNP
          patients_NNS (_( 33_CD %_NN )_) to_TO a_DT significantly_RB higher_JJR degree_NN than_IN in_IN
          OA_NNP (_( 10_CD %_NN )_) and_CC normal_JJ (_( 1_CD %_NN )_) cells_NNS (_( 
          P_NN <_NN 0_CD ._. 05_CD )_) (_( Fig_NNP ._. 1_LS )_) ._. Ang-_NNP 1_CD
          staining_VBG on_IN macrophages_NNS was_VBD also_RB significantly_RB higher_JJR in_IN
          RA_NNP (_( 39_CD %_NN )_) compared_VBN to_TO OA_NNP (_( 10_CD %_NN )_) and_CC normal_JJ cells_NNS (_( 0_CD %_NN )_) (_( 
          P_NN <_NN 0_CD ._. 05_CD )_) ._. The_DT Ang-_NNP 1_CD staining_VBG
          present_JJ on_IN vascular_NN endothelium_NN was_VBD upregulated_JJ in_IN RA_NNP
          (_( 86_CD %_NN )_) compared_VBN to_TO OA_NNP (_( 8_CD %_NN )_) and_CC normal_JJ synovial_NN tissues_NNS
          (_( 6_CD %_NN )_) ._. The_DT inflammatory_JJ and_CC vascularity_NN scores_NNS were_VBD higher_JJR
          in_IN RA_NNP synovial_NN tissue_NN in_IN comparison_NN to_TO OA_NNP and_CC normal_JJ ._. In_IN
          accordance_NN with_IN the_DT staining_VBG data_NN ,_, RA_NNP synovial_NN tissue_NN
          demonstrated_VBN significantly_RB higher_JJR Ang-_NNP 1_CD mRNA_NN expression_NN
          compared_VBN to_TO OA_NNP and_CC normal_JJ tissues_NNS ._. Ang-_NNP 1_CD mRNA_NN expression_NN
          was_VBD not_RB detected_VBN in_IN RA_NNP fibroblasts_NNS (_( Fig_NNP ._. 1_LS )_) ._.
        
        
          Ang-_NNP 2_CD
          The_DT expression_NN of_IN Ang-_NNP 2_CD was_VBD detected_VBN on_IN synovial_NN
          lining_NN cells_NNS ,_, macrophages_NNS and_CC vascular_NN endothelium_NN (_( Fig_NNP ._.
          2_LS )_) ._. The_DT data_NNS demonstrate_VBP that_IN Ang-_NNP 2_CD was_VBD expressed_VBN on_IN
          macrophages_NNS (_( 30_CD %_NN )_) and_CC the_DT vascular_NN endothelium_NN (_( 78_CD %_NN )_) in_IN
          synovial_NN tissue_NN of_IN RA_NNP patients_NNS more_RBR strongly_RB than_IN in_IN the_DT
          tissue_NN of_IN OA_NNP patients_NNS (_( macrophages_NNS 11_CD %_NN ,_, endothelium_NN 66_CD %_NN )_)
          and_CC normal_JJ subjects_NNS (_( macrophages_NNS 12_CD %_NN ,_, endothelium_NN 15_CD %_NN )_) ._.
          Additionally_RB ,_, Ang-_NNP 2_CD was_VBD detected_VBN in_IN the_DT synovial_NN vascular_NN
          smooth_JJ muscle_NN cells_NNS (_( 13_CD %_NN )_) from_IN RA_NNP patients_NNS only_RB ._.
          The_DT Ang-_NNP 2_CD mRNA_NN expression_NN pattern_NN was_VBD similar_JJ to_TO Ang-_NNP 2_CD
          immunostaining_VBG on_IN vascular_NN endothelium_NN ._. The_DT Ang-_NNP 2_CD mRNA_NN
          expression_NN in_IN RA_NNP synovial_NN tissue_NN was_VBD similar_JJ to_TO that_DT from_IN
          OA_NNP patients_NNS ,_, and_CC both_DT were_VBD significantly_RB higher_JJR than_IN
          normal_JJ ._. Interestingly_RB ,_, in_IN RA_NNP synovial_NN tissue_NN fibroblasts_NNS ,_,
          Ang-_NNP 2_CD mRNA_NN was_VBD expressed_VBN at_IN low_JJ levels_NNS compared_VBN to_TO that_DT
          found_VBD in_IN whole_JJ RA_NNP ,_, OA_NNP or_CC normal_JJ synovial_NN tissue_NN (_( Fig_NNP ._.
          2_LS )_) ._.
        
        
          Tie_NNP 1_CD
          Tie_NNP 1_CD expression_NN was_VBD found_VBN to_TO be_VB significantly_RB higher_JJR
          in_IN RA_NNP and_CC OA_NNP synovial_NN tissue_NN lining_NN cells_NNS (_( RA_NNP 79_CD %_NN ,_, OA_NNP
          81_CD %_NN )_) and_CC macrophages_NNS (_( RA_NNP 69_CD %_NN ,_, OA_NNP 66_CD %_NN )_) compared_VBN to_TO normal_JJ
          synovial_NN tissue_NN (_( lining_NN cells_NNS 24_CD %_NN ,_, macrophages_NNS 22_CD %_NN )_) using_VBG
          antibodies_NNS from_IN Santa_NNP Cruz_NNP Biotechnology_NNP (_( Fig_NNP ._. 3_LS )_) ._. Tie_NNP 1_CD
          immunostaining_VBG on_IN endothelial_NN cells_NNS was_VBD significantly_RB
          higher_JJR in_IN RA_NNP synovial_NN tissue_NN (_( 75_CD %_NN )_) in_IN comparison_NN to_TO OA_NNP
          (_( 3_CD %_NN )_) and_CC normal_JJ (_( 9_CD %_NN )_) synovial_NN tissue_NN ._. The_DT Tie_NNP 1_CD positive_JJ
          immunostaining_VBG on_IN vascular_NN smooth_JJ muscle_NN cells_NNS was_VBD
          similar_JJ in_IN all_DT test_NN groups_NNS (_( RA_NNP 74_CD %_NN ,_, OA_NNP 78_CD %_NN ,_, normal_JJ 71_CD %_NN )_) ._.
          Additionally_RB ,_, all_DT disease_NN groups_NNS demonstrated_VBD minimal_JJ
          percentages_NNS of_IN Tie_NNP 1_CD cell_NN staining_VBG on_IN synovial_NN tissue_NN
          lymphocytes_NNS (_( RA_NNP 1_CD %_NN ,_, OA_NNP 2_CD %_NN ,_, normal_JJ 6_CD %_NN )_) and_CC fibroblasts_NNS (_( RA_NNP
          18_CD %_NN ,_, OA_NNP 18_CD %_NN ,_, normal_JJ 30_CD %_NN )_) ._.
          Immunohistochemistry_NNP studies_NNS using_VBG the_DT goat_NN antihuman_NN
          Tie_NNP 1_CD antibody_NN purchased_VBN from_IN R_NN &_CC D_NNP Systems_NNPS showed_VBD
          predominantly_RB endothelial_NN cell_NN staining_VBG ,_, and_CC minimal_JJ
          staining_VBG on_IN macrophages_NNS and_CC fibroblasts_NNS ._. Tie_NNP 1_CD mRNA_NN
          expression_NN was_VBD significantly_RB higher_JJR in_IN RA_NNP synovial_NN tissue_NN
          compared_VBN to_TO OA_NNP synovial_NN tissue_NN (_( 3_CD -_: fold_VB )_) ,_, normal_JJ synovial_NN
          tissue_NN (_( 9_CD ._. 5_LS -_: fold_VB )_) and_CC RA_NNP synovial_NN tissue_NN fibroblasts_NNS
          (_( 6_CD -_: fold_VB )_) ._. Western_JJ blot_NN analysis_NN also_RB confirmed_VBD the_DT same_JJ
          pattern_NN of_IN expression_NN ._.
        
        
          Tie_NNP 2_CD
          Tie_NNP 2_CD was_VBD significantly_RB upregulated_JJ in_IN RA_NNP and_CC OA_NNP
          synovial_NN tissue_NN lining_NN cells_NNS (_( RA_NNP 71_CD %_NN ,_, OA_NNP 68_CD %_NN )_) ,_,
          macrophages_NNS (_( RA_NNP 71_CD %_NN ,_, OA_NNP 72_CD %_NN )_) and_CC smooth_JJ muscle_NN cells_NNS (_( RA_NNP
          71_CD %_NN ,_, OA_NNP 66_CD %_NN )_) compared_VBN to_TO normal_JJ synovial_NN tissue_NN (_( 
          P_NN <_NN 0_CD ._. 05_CD )_) using_VBG the_DT Santa_NNP Cruz_NNP
          antibodies_NNS (_( Fig_NNP ._. 4_LS )_) ._. Endothelial_NNP cells_NNS showed_VBD relatively_RB
          high_JJ Tie_NNP 2_CD positive_JJ staining_VBG in_IN all_DT disease_NN groups_NNS (_( RA_NNP
          71_CD %_NN ,_, OA_NNP 66_CD %_NN ,_, normal_JJ 49_CD %_NN )_) ._. Only_RB synovial_NN tissue_NN from_IN RA_NNP
          patients_NNS demonstrated_VBD positive_JJ staining_VBG for_IN Tie_NNP 2_CD on_IN
          lymphocytes_NNS ._. RA_NNP and_CC OA_NNP patients_NNS had_VBD similar_JJ patterns_NNS of_IN
          Ang-_NNP 2_CD (_( on_IN cell_NN lining_NN and_CC endothelial_NN cells_NNS )_) ,_, Tie_NNP 1_CD (_( on_IN
          lining_NN cells_NNS ,_, macrophages_NNS ,_, smooth_JJ muscle_NN cells_NNS ,_,
          lymphocytes_NNS and_CC fibroblasts_NNS )_) and_CC Tie_NNP 2_CD (_( on_IN lining_NN cells_NNS ,_,
          macrophages_NNS ,_, endothelial_NN cells_NNS and_CC vascular_NN smooth_JJ muscle_NN
          cells_NNS )_) expression_NN on_IN various_JJ synovial_NN tissue_NN components_NNS ._.
          The_DT anti-_NN Tie_NNP 2_CD antibody_NN from_IN R_NN &_CC D_NNP Systems_NNPS demonstrated_VBD
          positive_JJ staining_VBG mainly_RB on_IN endothelial_NN cells_NNS and_CC minimal_JJ
          staining_VBG on_IN macrophages_NNS and_CC fibroblasts_NNS ._. Tie_NNP 2_CD mRNA_NN levels_NNS
          were_VBD significantly_RB higher_JJR in_IN RA_NNP synovial_NN tissue_NN compared_VBN
          to_TO OA_NNP synovial_NN tissue_NN (_( 1_CD ._. 9_CD -_: fold_VB )_) ,_, normal_JJ synovial_NN tissue_NN
          (_( 4_CD -_: fold_VB )_) and_CC RA_NNP synovial_NN tissue_NN fibroblasts_NNS (_( 9_CD ._. 6_CD -_: fold_VB )_) ._.
          Tie_NNP 2_CD protein_NN expression_NN by_IN western_JJ blotting_VBG followed_VBD the_DT
          same_JJ pattern_NN as_IN the_DT mRNA_NN expression_NN (_( Fig_NNP ._. 4_LS )_) ._.
        
      
      
        Discussion_NNP
        The_DT Tie_NNP receptors_NNS and_CC the_DT ligands_NNS Ang-_NNP 1_CD and_CC Ang-_NNP 2_CD appear_VB
        to_TO be_VB involved_VBN in_IN the_DT later_JJ stages_VBZ of_IN vessel_NN growth_NN and_CC
        remodeling_VBG [_NN 8_CD 13_CD ]_NN ._. Transgenic_NNP mice_NNS with_IN gene_NN deletions_NNS [_NN
        7_CD 8_CD 13_CD ]_NN or_CC overexpression_NN of_IN Ang-_NNP 2_CD [_NN 6_CD ]_NN exhibit_NN early_JJ
        embryonic_JJ lethality_NN secondary_JJ to_TO defects_NNS in_IN the_DT developing_VBG
        vasculature_NN ._.
        Ang-_NNP 1_CD was_VBD more_RBR highly_RB expressed_VBD in_IN synovial_NN tissue_NN from_IN
        RA_NNP patients_NNS than_IN in_IN either_DT OA_NNP or_CC normal_JJ synovial_NN tissues_NNS ;_:
        expression_NN in_IN OA_NNP tissue_NN was_VBD similar_JJ to_TO normal_JJ ._. Positive_JJ
        cells_NNS included_VBD lining_VBG cells_NNS ,_, macrophages_NNS and_CC endothelial_NN
        cells_NNS ._. In_IN RA_NNP ,_, Ang-_NNP 1_CD was_VBD most_RBS upregulated_JJ on_IN endothelial_NN
        cells_NNS ._. The_DT results_NNS obtained_VBN from_IN RT-PCR_NNP analysis_NN confirmed_VBD
        that_IN RA_NNP synovial_NN tissue_NN had_VBD significantly_RB higher_JJR Ang-_NNP 1_CD mRNA_NN
        expression_NN than_IN OA_NNP and_CC normal_JJ synovial_NN tissue_NN ._. Hence_RB ,_, no_DT
        Ang-_NNP 1_CD mRNA_NN expression_NN was_VBD detected_VBN in_IN RA_NNP fibroblasts_NNS (_( Fig_NNP ._.
        1_LS )_) ._. The_DT Tie_NNP receptor_NN family_NN is_VBZ known_VBN to_TO be_VB expressed_VBN on_IN
        endothelial_NN cells_NNS [_NN 5_CD ]_NN ._. Otani_NNP 
        et_CC al_NN [_NN 14_CD ]_NN reported_VBD Ang-_NNP 1_CD and_CC Ang-_NNP 2_CD
        positive_JJ staining_VBG on_IN macrophages_NNS and_CC endothelial_NN cells_NNS in_IN
        choroidal_NN neovascular_NN membranes_NNS ._. Macrophages_NNP are_VBP key_JJ
        angiogenesis_NNS effector_NN cells_NNS that_WDT produce_VBP a_DT number_NN of_IN growth_NN
        factor_NN stimulators_NNS and_CC inhibitors_NNS ,_, proteolytic_JJ enzymes_NNS and_CC
        cytokines_NNS that_WDT can_MD activate_VBP one_CD or_CC more_JJR steps_NNS in_IN the_DT
        angiogenesis_NNS cascade_NN [_NN 15_CD 16_CD 17_CD ]_NN ._. Recent_JJ studies_NNS have_VBP
        shown_VBN that_IN angiopoietins_NNS promote_VBP postnatal_NN
        neovascularization_NN by_IN potentiating_VBG angiogenic_JJ cytokines_NNS
        such_JJ as_IN VEGF_NNP [_NN 9_CD 10_CD ]_NN ._.
        
        In_IN situ_NN hybridization_NN and_CC
        immunohistochemical_JJ analyses_NNS of_IN RA_NNP synovial_NN biopsies_NNS
        revealed_VBD that_IN VEGF_NNP mRNA_NN and_CC protein_NN localized_VBN to_TO
        subsynovial_NN macrophages_NNS ,_, lining_NN cells_NNS ,_, vascular_NN smooth_JJ
        muscle_NN cells_NNS and_CC fibroblasts_NNS within_IN the_DT pannus_JJ ,_, which_WDT are_VBP
        the_DT putative_JJ target_NN of_IN this_DT cytokine_NN [_NN 18_CD 19_CD ]_NN ._. The_DT
        localization_NN of_IN Ang-_NNP 1_CD is_VBZ similar_JJ to_TO that_DT of_IN VEGF_NNP ,_, which_WDT
        further_JJ supports_VBZ the_DT crucial_JJ role_NN of_IN the_DT interaction_NN
        between_IN these_DT two_CD pathways_NNS ._. Ang-_NNP 1_CD modulates_NNS VEGF-stimulated_NNP
        reorganization_NN of_IN endothelial_NN cells_NNS and_CC promotes_VBZ vascular_NN
        network_NN maturation_NN [_NN 9_CD 20_CD ]_NN ._. Additionally_RB ,_, both_DT Ang-_NNP 1_CD and_CC
        VEGF_NNP are_VBP chemotactic_JJ and_CC are_VBP involved_VBN in_IN recruiting_VBG
        endothelial_NN cells_NNS to_TO initiate_VB and_CC accelerate_VB
        endothelialization_NN of_IN blood_NN vessels_NNS [_NN 21_CD 22_CD ]_NN ._.
        We_PRP detected_VBD Ang-_NNP 2_CD immunopositive_JJ cells_NNS in_IN synovial_NN
        lining_NN ,_, macrophages_NNS and_CC vascular_NN endothelium_NN ._. Vascular_NNP
        smooth_JJ muscle_NN immunostaining_VBG was_VBD found_VBN only_RB in_IN RA_NNP ._. In_IN
        agreement_NN with_IN our_PRP$ finding_VBG ,_, it_PRP has_VBZ been_VBN reported_VBN that_IN
        primary_JJ cultured_JJ macrophages_NNS and_CC precursor_NN macrophage_NN cell_NN
        lines_NNS mainly_RB express_VBP Ang-_NNP 2_CD mRNA_NN [_NN 23_CD ]_NN ._. In_IN contrast_NN to_TO
        Ang-_NNP 1_CD ,_, Ang-_NNP 2_CD was_VBD distributed_VBN in_IN a_DT similar_JJ pattern_NN in_IN RA_NNP and_CC
        OA_NNP compared_VBD to_TO normal_JJ synovial_NN tissues_NNS (_( Fig_NNP ._. 2_LS )_) ._. The_DT
        dominance_NN of_IN Ang-_NNP 2_CD over_IN Ang-_NNP 1_CD mRNA_NN and_CC protein_NN in_IN OA_NNP
        synovial_NN tissue_NN are_VBP in_IN agreement_NN with_IN the_DT inactive_JJ VEGF_NNP
        receptor_NN 1_CD pathway_NN (_( angiogenic_JJ pathway_NN )_) in_IN OA_NNP [_NN 24_CD ]_NN ._. The_DT
        Ang-_NNP 2_CD mRNA_NN expression_NN pattern_NN correlates_NNS with_IN the_DT Ang-_NNP 2_CD
        immunostaining_VBG detected_VBN on_IN endothelial_NN cells_NNS ._. In_IN RA_NNP
        synovial_NN tissue_NN ,_, Ang-_NNP 2_CD showed_VBD a_DT lower_JJR percentage_NN of_IN
        staining_VBG in_IN all_PDT the_DT cell_NN types_NNS compared_VBN to_TO Ang-_NNP 1_CD ._. Low_NNP Ang-_NNP 2_CD
        mRNA_NN expression_NN was_VBD also_RB detected_VBN on_IN RA_NNP fibroblasts_NNS ._.
        Interestingly_RB Ang-_NNP 2_CD acts_NNS as_IN an_DT agonist_NN for_IN Tie_NNP 2_CD receptors_NNS
        expressed_VBD on_IN fibroblasts_NNS [_NN 6_CD ]_NN ._. Since_IN the_DT
        neovascularization_NN process_NN is_VBZ dependent_JJ on_IN the_DT dominance_NN of_IN
        angiogenic_JJ mediators_NNS over_IN inhibitors_NNS ,_, the_DT higher_JJR Ang-_NNP 1_CD mRNA_NN
        and_CC protein_NN expression_NN compared_VBN to_TO Ang-_NNP 2_CD in_IN RA_NNP synovial_NN
        tissue_NN is_VBZ of_IN importance_NN ._. It_PRP has_VBZ been_VBN shown_VBN that_IN increasing_VBG
        amounts_NNS of_IN Ang-_NNP 2_CD can_MD block_VB the_DT chemotactic_JJ activity_NN of_IN
        Ang-_NNP 1_CD in_IN endothelial_NN cells_NNS [_NN 21_CD ]_NN ._. Ang-_NNP 2_CD alone_RB did_VBD not_RB
        stimulate_VB corneal_JJ neovascularization_NN ,_, but_CC the_DT combination_NN
        of_IN Ang-_NNP 2_CD and_CC VEGF_NNP resulted_VBD in_IN longer_JJR vessels_NNS with_IN greater_JJR
        circumferential_NN extent_NN than_IN those_DT seen_VBN with_IN VEGF_NNP alone_RB [_NN 9_CD
        ]_NN ._. This_DT suggests_VBZ that_IN Ang-_NNP 2_CD expression_NN in_IN the_DT absence_NN of_IN
        VEGF_NNP leads_VBZ to_TO vessel_NN regression_NN ,_, whereas_IN expression_NN of_IN
        Ang-_NNP 2_CD in_IN the_DT presence_NN of_IN VEGF_NNP potentiates_NNS angiogenesis_NNS ._.
        Using_VBG the_DT Santa_NNP Cruz_NNP Biotechnology_NNP antibody_NN ,_, Tie_NNP 1_CD
        expression_NN was_VBD detected_VBN on_IN all_DT cell_NN components_NNS examined_VBD ,_,
        including_VBG a_DT percentage_NN of_IN synovial_NN lining_NN cells_NNS ,_,
        macrophages_NNS and_CC smooth_JJ muscle_NN cells_NNS in_IN RA_NNP and_CC OA_NNP ._. Synovial_NNP
        tissues_NNS from_IN normal_JJ subjects_NNS ,_, and_CC those_DT with_IN OA_NNP ,_, had_VBD
        considerably_RB lower_JJR positive_JJ immunostaining_VBG on_IN endothelial_NN
        cells_NNS compared_VBN to_TO RA_NNP tissues_NNS ._. Immunohistochemical_NNP analysis_NN
        performed_VBN with_IN anti-_NN Tie_NNP 1_CD from_IN R_NN &_CC D_NNP Systems_NNPS in_IN synovial_NN
        tissues_NNS supports_VBZ its_PRP$ expression_NN mainly_RB on_IN endothelial_NN
        cells_NNS ._. However_RB ,_, western_JJ blot_NN analysis_NN for_IN Tie_NNP 1_CD also_RB
        performed_VBN with_IN an_DT antibody_NN from_IN R_NN &_CC D_NNP Systems_NNPS ,_, showed_VBD
        higher_JJR relative_JJ abundance_NN of_IN Tie_NNP 1_CD in_IN whole_JJ RA_NNP and_CC OA_NNP
        synovial_NN tissue_NN homogenates_NNS compared_VBN to_TO RA_NNP fibroblasts_NNS
        (_( Fig_NNP ._. 3_LS )_) ._. In_IN accordance_NN with_IN the_DT protein_NN data_NN ,_, the_DT mRNA_NN
        levels_NNS of_IN Tie_NNP 1_CD in_IN RA_NNP synovial_NN tissue_NN were_VBD upregulated_JJ
        compared_VBN to_TO OA_NNP synovial_NN tissue_NN ,_, normal_JJ synovial_NN tissue_NN and_CC
        RA_NNP fibroblasts_NNS ._. Since_IN the_DT ligand_NN for_IN the_DT Tie_NNP 1_CD receptor_NN is_VBZ
        not_RB known_VBN ,_, it_PRP is_VBZ difficult_JJ to_TO speculate_VB if_IN there_EX is_VBZ any_DT
        correlation_NN between_IN this_DT receptor_NN and_CC Tie_NNP 2_CD and_CC its_PRP$ ligands_NNS ._.
        In_IN agreement_NN with_IN previous_JJ studies_NNS ,_, the_DT Tie_NNP 1_CD receptor_NN was_VBD
        detected_VBN on_IN vascular_NN endothelial_NN cells_NNS [_NN 4_CD 25_CD ]_NN and_CC
        recently_RB on_IN synovial_NN lining_NN cells_NNS [_NN 26_CD ]_NN ._. It_PRP has_VBZ been_VBN
        shown_VBN that_IN tumor_NN necrosis_NNS factor-α_JJ and_CC VEGF_NNP activate_VBP
        membrane-associated_JJ metalloproteinases_NNS that_WDT release_NN soluble_JJ
        Tie_NNP 1_CD from_IN the_DT cell_NN surface_NN of_IN endothelial_NN cells_NNS and_CC thereby_RB
        decrease_VB membrane-bound_JJ Tie_NNP 1_CD expression_NN [_NN 27_CD ]_NN ._. The_DT
        upregulation_NN of_IN Tie_NNP 1_CD mRNA_NN and_CC protein_NN expression_NN in_IN RA_NNP is_VBZ
        not_RB consistent_JJ with_IN these_DT findings_NNS and_CC this_DT may_MD be_VB due_JJ to_TO
        the_DT fact_NN that_IN the_DT inflammatory_JJ milieu_NN in_IN RA_NNP synovial_NN tissue_NN
        is_VBZ far_RB more_RBR complex_JJ than_IN the_DT 
        in_IN vitro_NN system_NN ._.
        Using_VBG the_DT Santa_NNP Cruz_NNP Biotechnology_NNP antibody_NN we_PRP showed_VBD
        that_IN Tie_NNP 2_CD expression_NN was_VBD significantly_RB upregulated_JJ both_DT in_IN
        RA_NNP and_CC OA_NNP synovial_NN tissue_NN lining_NN cells_NNS ,_, macrophages_NNS ,_,
        endothelial_NN cells_NNS and_CC vascular_NN smooth_JJ muscle_NN compared_VBN to_TO
        normal_JJ synovial_NN tissue_NN ._. In_IN accordance_NN with_IN Otani_NNP 
        et_CC al_NN ._. [_NN 14_CD ]_NN and_CC Uchida_NNP 
        et_CC al_NN ._. [_NN 26_CD ]_NN we_PRP detected_VBD Tie_NNP 2_CD
        immunostaining_VBG on_IN endothelial_NN cells_NNS and_CC fibroblasts_NNS in_IN all_DT
        disease_NN groups_NNS ._. Tie_NNP 2_CD immunostaining_VBG using_VBG antibody_NN from_IN
        R_NN &_CC D_NNP Systems_NNPS confirmed_VBD the_DT expression_NN of_IN this_DT antigen_NN
        mainly_RB on_IN endothelial_NN cells_NNS ._. Tie_NNP 2_CD mRNA_NN and_CC protein_NN
        expression_NN followed_VBD the_DT same_JJ pattern_NN of_IN expression_NN as_IN Tie_NNP 1_CD ._.
        There_EX are_VBP some_DT possible_JJ reasons_NNS why_WRB the_DT
        immunohistochemistry_NN studies_NNS performed_VBN with_IN Santa_NNP Cruz_NNP
        Biotechnology_NNP /_NN R_NN &_CC D_NNP Systems_NNPS antibodies_NNS differ_VBP ._. The_DT Santa_NNP
        Cruz_NNP Biotechnology_NNP antibodies_NNS detected_VBD epitopes_NNS on_IN the_DT
        carboxy_NN terminus_JJ whereas_IN the_DT R_NN &_CC D_NNP Systems_NNPS antibodies_NNS
        recognized_VBD the_DT extracelluar_NN domain_NN (_( N_NNP terminus_JJ or_CC the_DT
        ligand_NN binding_JJ domain_NN )_) of_IN Tie_NNP 1_CD and_CC Tie_NNP 2_CD ._. There_EX is_VBZ also_RB some_DT
        variability_NN between_IN individual_JJ RA_NNP patient_NN samples_NNS ,_, however_RB ,_,
        we_PRP attempted_VBD to_TO use_VB the_DT same_JJ RA_NNP patient_NN samples_NNS in_IN
        performing_VBG immunohistochemistry_NN with_IN the_DT two_CD different_JJ
        antibodies_NNS ._. Additionally_RB ,_, the_DT results_NNS obtained_VBN from_IN the_DT
        RT-PCR_NNP and_CC western_JJ blot_NN analysis_NN confirm_VB our_PRP$ findings_NNS ._.
      
      
        Conclusion_NNP
        It_PRP is_VBZ noteworthy_JJ that_IN the_DT activating_VBG ligand_NN ,_, Ang-_NNP 1_CD is_VBZ
        exclusively_RB higher_JJR than_IN Ang-_NNP 2_CD at_IN the_DT mRNA_NN and_CC protein_NN
        levels_NNS in_IN RA_NNP synovial_NN tissue_NN compared_VBN to_TO that_DT from_IN patients_NNS
        with_IN OA_NNP and_CC normal_JJ subjects_NNS ._. Hypothetically_NNP ,_, in_IN RA_NNP synovial_NN
        tissue_NN the_DT dominating_VBG Ang-_NNP 1_CD induces_VBZ the_DT Tie_NNP 2_CD pathway_NN ,_,
        whereas_IN in_IN normal_JJ synovial_NN tissue_NN higher_JJR Ang-_NNP 2_CD presence_NN
        blocks_NNS Ang-_NNP 1_CD binding_JJ to_TO Tie_NNP 2_CD and_CC inhibits_NNS its_PRP$
        autophosphorylation_NN ._.
        In_IN conclusion_NN ,_, the_DT dominance_NN of_IN Ang-_NNP 1_CD over_IN Ang-_NNP 2_CD
        expression_NN favors_VBZ active_JJ neovascularization_NN in_IN RA_NNP synovial_NN
        tissue_NN ._. Multiple_NNP pathways_NNS are_VBP probably_RB required_VBN to_TO regulate_VB
        angiogenesis_NNS ._. It_PRP may_MD be_VB that_IN the_DT inhibition_NN of_IN the_DT VEGF_NNP and_CC
        Tie_NNP 2_CD pathways_NNS might_MD be_VB an_DT effective_JJ therapeutic_JJ modality_NN in_IN
        RA_NNP ._.
      
      
        Abbreviations_NNP
        Ang_NNP =_SYM angiopoietin_NN ;_: BSA_NNP =_SYM bovine_JJ serum_NN albumin_NN ;_: FBS_NNP =_SYM
        fetal_JJ bovine_JJ serum_NN ;_: HMVEC_NNP =_SYM human_JJ microvascular_NN endothelial_NN
        cell_NN ;_: OA_NNP =_SYM osteoarthritis_NNS ;_: PCR_NNP =_SYM polymerase_NN chain_NN reaction_NN ;_:
        RA_NNP =_SYM rheumatoid_NN arthritis_NN ;_: RT-PCR_NNP =_SYM reverse_VB transcription_NN
        polymerase_NN chain_NN reaction_NN ,_, SE_NNP =_SYM standard_JJ error_NN ;_: Tie_NNP =_SYM
        receptor_NN tyrosine_NN kinase_NN ;_: VEGF_NNP =_SYM vascular_NN endothelial_NN
        growth_NN factor_NN ._.
      
      
        Supplementary_NNP material_NN
        
          Materials_NNS and_CC methods_NNS
        
        
          Patient_NNP population_NN
          Synovial_NNP tissues_NNS from_IN patients_NNS with_IN RA_NNP and_CC OA_NNP ,_,
          undergoing_VBG arthroplasty_NN or_CC synovectomy_NN ,_, who_WP fulfilled_VBD the_DT
          criteria_NNS set_VBN by_IN the_DT American_NNP College_NNP of_IN Rheumatology_NNP were_VBD
          obtained_VBN with_IN Institutional_NNP Review_NNP Board_NNP (_( IRB_NNP )_) consent_NN [_NN
          28_CD 29_CD ]_NN ._. Normal_NNP synovial_NN tissues_NNS were_VBD obtained_VBN from_IN
          fresh_JJ autopsies_NNS or_CC amputations_NNS ._. Synovial_NNP tissues_NNS were_VBD
          snap_NN frozen_VBN in_IN Optimal_NNP Cutting_VBG Temperature_NNP (_( OCT_NNP )_) compound_NN
          (_( Miles_NNP ,_, Elkhart_NNP ,_, IN_IN ,_, USA_NNP )_) ._.
        
        
          Microscopic_NNP analysis_NN
          Synovial_NNP tissue_NN components_NNS including_VBG lining_NN cells_NNS ,_,
          macrophages_NNS ,_, lymphocytes_NNS ,_, fibroblasts_NNS ,_, smooth_JJ muscle_NN
          cells_NNS and_CC endothelial_NN cells_NNS were_VBD graded_JJ for_IN
          immunostaining_VBG by_IN a_DT frequency_NN of_IN staining_VBG scale_NN ,_, scored_VBD
          0_CD -_: 100_CD %_NN ,_, where_WRB 0_CD %_NN indicates_VBZ no_DT staining_VBG and_CC 100_CD %_NN indicates_VBZ
          that_IN all_DT cells_NNS were_VBD immunoreactive_JJ ._. Five_CD 400_CD ×_NN fields_NNS were_VBD
          examined_VBN per_IN section_NN by_IN a_DT single_JJ pathologist_NN in_IN a_DT blinded_JJ
          study_NN ._. Selected_JJ sections_NNS were_VBD analyzed_VBN by_IN two_CD additional_JJ
          observers_NNS ._.
        
        
          Statistical_NNP analysis_NN
          Data_NNP were_VBD analyzed_VBN using_VBG a_DT Kruskal_NNP Wallis_NNP test_NN ._. There_EX
          were_VBD 5_CD to_TO 15_CD patient_NN samples_NNS per_IN group_NN ._. 
          P_NN values_NNS <_NN 0_CD ._. 05_CD were_VBD considered_VBN
          to_TO be_VB significant_JJ ._.
        
        
          Cell_NNP culture_NN
          Fibroblasts_NNP were_VBD isolated_VBN from_IN synovial_NN tissues_NNS that_WDT
          had_VBD been_VBN minced_JJ and_CC digested_VBN in_IN a_DT solution_NN of_IN dispase_NN ,_,
          collagenase_NN and_CC DNase_NNP ._. Synovial_NNP tissue_NN fibroblasts_NNS were_VBD
          cultured_JJ in_IN Roswell_NNP Park_NNP Memorial_NNP Institute_NNP (_( RPMI_NNP )_) -_: 1640_CD
          supplemented_JJ with_IN 10_CD %_NN FBS_NNP and_CC 1_CD %_NN penicillin_NN /_NN streptomycin_NN
          (_( P_NN /_NN S_NNP )_) and_CC used_VBN at_IN passage_NN five_CD or_CC older_JJR ,_, at_IN which_WDT time_NN
          they_PRP were_VBD a_DT homogeneous_JJ population_NN of_IN fibroblasts_NNS ._.
          Human_JJ microvascular_NN endothelial_NN cells_NNS (_( HMVECs_NNP )_)
          (_( BioWhittaker_NNP ,_, CA_NNP ,_, USA_NNP )_) were_VBD cultured_JJ in_IN endothelial_NN cell_NN
          growth_NN medium-_NN 2_CD for_IN microvascular_NN cells_NNS (_( BioWhittaker_NNP ,_,
          Walkerville_NNP ,_, MD_NNP ,_, USA_NNP )_) and_CC were_VBD used_VBN between_IN passages_NNS 3_CD
          and_CC 12_CD ._. Upon_IN confluence_NN ,_, the_DT cells_NNS were_VBD passaged_JJ by_IN brief_JJ
          trypsinisation_NN as_RB previously_RB described_VBD [_NN 30_CD ]_NN ._. HMVECs_NNP
          were_VBD used_VBN as_IN positive_JJ controls_NNS for_IN Tie_NNP 1_CD and_CC Tie_NNP 2_CD protein_NN
          expression_NN in_IN western_JJ blot_NN analysis_NN ._.
        
        
          RNA_NNP purification_NN
          Total_NNP RNA_NNP was_VBD prepared_VBN from_IN synovial_NN tissue_NN by_IN an_DT acid_NN
          phenol_NN method_NN according_VBG to_TO the_DT procedure_NN described_VBN by_IN
          Chomczynski_NNP and_CC Sacchi_NNP [_NN 31_CD ]_NN ._. RNA_NNP (_( 20_CD μg_NN )_) was_VBD digested_VBN
          with_IN five_CD units_NNS of_IN DNase_NNP in_IN 1_CD ×_NN reverse_NN transcription_NN
          buffer_NN (_( Gibco_NNP /_NN Life_NNP Technologies_NNPS ,_, Grand_NNP Island_NNP ,_, NY_NNP ,_, USA_NNP )_)
          containing_VBG eight_CD units_NNS of_IN RNase_NNP inhibitor_NN (_( Gibco_NNP /_NN Life_NNP
          Technologies_NNPS ,_, Grand_NNP Island_NNP ,_, NY_NNP ,_, USA_NNP )_) for_IN 30_CD minutes_NNS at_IN
          37_CD °_NN C_NNP ._. Sodium_NNP acetate_NN (_( 2_CD M_NNP ,_, pH_NN 4_CD ._. 0_CD )_) was_VBD added_VBN (_( 10_CD %_NN of_IN the_DT
          total_JJ volume_NN )_) ,_, and_CC the_DT solution_NN was_VBD extracted_VBN with_IN one_CD
          volume_NN each_DT of_IN water-saturated_JJ phenol_NN and_CC chloroform_NN
          (_( Fisher_NNP ,_, Itasca_NNP ,_, IL_NNP ,_, USA_NNP )_) ._. The_DT RNA_NNP was_VBD precipitated_VBD with_IN
          ethanol_NN ,_, washed_VBN with_IN 75_CD %_NN ethanol_NN ,_, then_RB air-dried_JJ ._. The_DT
          pellet_NN was_VBD dissolved_VBN in_IN water_NN at_IN 1_CD μg_NN /_NN μl_NN ._.
        
        
          Reverse_VBP transcription_NN
          Reverse_VBP transcription_NN of_IN RNA_NNP was_VBD performed_VBN using_VBG 5_CD μg_NN
          of_IN RNA_NNP in_IN a_DT total_JJ volume_NN of_IN 20_CD μl_NN ._. The_DT RNA_NNP was_VBD reverse_VB
          transcribed_JJ by_IN Superscript_NNP II_NNP RT_NNP (_( Gibco_NNP /_NN Life_NNP
          Technologies_NNPS ,_, Grand_NNP Island_NNP ,_, NY_NNP ,_, USA_NNP )_) according_VBG to_TO
          manufacturer_NN 's_POS specification_NN ._. After_IN 10_CD minutes_NNS at_IN 25_CD °_NN C_NNP ,_,
          the_DT enzyme_NN was_VBD incubated_JJ at_IN 42_CD °_NN C_NNP for_IN 50_CD minutes_NNS and_CC
          thereafter_RB inactivated_JJ at_IN 70_CD °_NN C_NNP for_IN 15_CD minutes_NNS ._. The_DT
          solution_NN was_VBD diluted_VBN to_TO 40_CD μl_NN ._. All_DT samples_NNS were_VBD reverse_VB
          transcribed_JJ simultaneously_RB ._.
        
        
          Standard_JJ dilution_NN preparation_NN and_CC PCR_NNP
          All_DT PCR_NNP reactions_NNS were_VBD performed_VBN on_IN an_DT ABI_NNP Prism_NNP 7700_CD
          Sequence_NNP Detection_NNP System_NNP (_( Perkin_NNP Elmer_NNP Applied_NNP
          Biosys-tem_NNP ,_, CA_NNP ,_, USA_NNP )_) ._. For_IN each_DT PCR_NNP run_VBD ,_, a_DT master_NN mixture_NN
          was_VBD prepared_VBN on_IN ice_NN with_IN 1_CD ×_NN Platinum_NN PCR_NNP buffer_NN
          (_( Gibco_NNP /_NN Life_NNP Technologies_NNPS ,_, Grand_NNP Island_NNP ,_, NY_NNP ,_, USA_NNP )_) ,_, 1_CD ._. 5_CD mM_NN
          MgCl_NNP 
          2_CD ,_, 0_CD ._. 2_CD mM_NN of_IN each_DT deoxynucleoside_NN
          triphosphate_NN ,_, 0_CD ._. 2_CD μM_NN each_DT primer_NN ,_, 2_CD ._. 5_CD units_NNS platinum_NN Taq_NNP
          DNA_NNP polymerase_NN (_( Gibco_NNP /_NN Life_NNP Technologies_NNPS ,_, Grand_NNP Island_NNP ,_,
          NY_NNP ,_, USA_NNP )_) ._. The_DT diluted_VBN reverse_NN transcription_NN sample_NN (_( 3_CD μl_NN )_)
          was_VBD added_VBN to_TO 25_CD μl_NN of_IN the_DT PCR_NNP mix_NN ._. The_DT thermal_JJ cycling_NN
          conditions_NNS were_VBD 40_CD cycles_NNS of_IN the_DT denaturation_NN step_NN at_IN
          95_CD °_NN C_NNP for_IN 30_CD seconds_NNS ,_, annealing_VBG at_IN 60_CD °_NN C_NNP for_IN one_CD minute_NN and_CC
          an_DT extention_NN step_NN at_IN 72_CD °_NN C_NNP for_IN one_CD minute_NN ._. PCR_NNP products_NNS
          were_VBD extracted_VBN from_IN agarose_NN gels_NNS and_CC purified_JJ ._. Serial_JJ
          dilutions_NNS of_IN PCR_NNP products_NNS were_VBD then_RB prepared_VBN which_WDT ranged_VBD
          from_IN 10_CD 1_CD to_TO 10_CD 10_CD molecules_NNS [_NN 32_CD ]_NN ._. The_DT sequence_NN for_IN the_DT
          designed_VBN Tie_NNP receptors_NNS and_CC ligands_NNS are_VBP shown_VBN in_IN
          Supplementary_NNP Table_NNP 1_CD ._.
        
        
          Real-time_NNP quantitative_JJ RT-PCR_NNP using_VBG the_DT TaqMan_NNP
          system_NN
          The_DT PCR_NNP primer_NN and_CC the_DT TaqMan_NNP fluorogenic_JJ probe_NN were_VBD
          designed_VBN using_VBG the_DT Primer_NNP Express_NNP program_NN v_NN 1_CD ._. 01_CD (_( Perkin_NNP
          Elmer_NNP Applied_NNP Biosystem_NNP ,_, CA_NNP ,_, USA_NNP )_) ._. The_DT TaqMan_NNP probe_NN
          carries_VBZ a_DT 5_CD '_POS FAM_NNP (_( 6_CD -_: carboxy-fluorescein_JJ )_) reporter_NN dye_NN and_CC
          a_DT 3_CD '_POS TAMRA_NNP (_( 6_CD -_: carboxy-tetramethyl-rhodamine_JJ )_) quencher_NN dye_NN
          (_( Mega_JJ Bases_NNP ,_, Chicago_NNP ,_, IL_NNP ,_, USA_NNP )_) The_DT quantity_NN of_IN cDNA_NN of_IN
          the_DT gene_NN of_IN interest_NN was_VBD directly_RB related_VBN to_TO the_DT
          fluorescence_NN detection_NN of_IN FAM_NNP after_IN 40_CD cycles_NNS ._. The_DT amount_NN
          of_IN cDNA_NN was_VBD calculated_VBN using_VBG a_DT comparative_JJ C_NNP 
          T_NN method_NN and_CC the_DT standard_JJ curve_NN method_NN
          [_NN 33_CD ]_NN according_VBG to_TO Perkin_NNP Elmer_NNP ABI_NNP PRISM_NNP 7700_CD User_NNP
          Bulletin_NNP No_UH ._. 2_LS ,_, 1997_CD ._. The_DT calibration_NN curves_NNS showed_VBD a_DT
          strong_JJ linear_JJ correlation_NN ,_, with_IN correlation_NN coefficients_NNS
          between_IN 0_CD ._. 96_CD and_CC 0_CD ._. 99_CD ._. In_IN both_DT methods_NNS ,_, the_DT estimated_VBN
          amount_NN of_IN the_DT gene_NN of_IN interest_NN was_VBD normalized_JJ by_IN the_DT
          amount_NN of_IN glyceraldehyde-_NN 3_CD -_: phosphate_NN dehydrogenase_NN to_TO
          compensate_VB for_IN variations_NNS in_IN quantity_NN and_CC for_IN differences_NNS
          in_IN reverse_NN transcription_NN efficiency_NN ._.
          Briefly_NNP ,_, 3_CD μl_NN of_IN the_DT cDNA_NN was_VBD in_IN a_DT reaction_NN of_IN 25_CD μl_NN
          that_WDT contained_VBD final_JJ concentrations_NNS of_IN 1_CD ×_NN Platinum_NN PCR_NNP
          buffer_NN (_( Gibco_NNP /_NN Life_NNP Technologies_NNPS ,_, Grand_NNP Island_NNP ,_, NY_NNP ,_, USA_NNP )_) ,_,
          3_CD ._. 5_CD mM_NN MgCl_NNP 
          2_CD ,_, 200_CD μM_NN dNTP_NN ,_, 500_CD nM_NN each_DT primer_NN
          (_( Mega_JJ Bases_NNP ,_, Chicago_NNP ,_, IL_NNP ,_, USA_NNP )_) ,_, 200_CD nM_NN FAM-TAMRA_NNP probe_NN
          (_( Mega_JJ Bases_NNP ,_, IL_NNP ,_, USA_NNP )_) ,_, 100_CD nM_NN Blue_NNP 636_CD (_( BD_NNP 636_CD )_) ,_, 0_CD ._. 05_CD
          units_NNS platinum_NN Taq_NNP DNA_NNP polymerase_NN (_( Gibco_NNP /_NN Life_NNP
          Technologies_NNPS ,_, Grand_NNP Island_NNP ,_, NY_NNP ,_, USA_NNP )_) ._. The_DT thermal_JJ cycling_NN
          conditions_NNS included_VBD 94_CD °_NN C_NNP for_IN five_CD minutes_NNS ,_, followed_VBN by_IN 40_CD
          cycles_NNS of_IN amplification_NN at_IN 94_CD °_NN C_NNP for_IN 30_CD seconds_NNS and_CC 60_CD °_NN C_NNP
          for_IN one_CD minute_NN for_IN denaturing_VBG and_CC annealing-extension_JJ ,_,
          respectively_RB ._. All_DT samples_NNS were_VBD amplified_VBN in_IN
          triplicate_NN ._.
        
        
          Western_JJ blot_NN analysis_NN
          Synovial_NNP tissues_NNS were_VBD homogenized_JJ in_IN a_DT 50_CD ml_NN conical_JJ
          centrifuge_NN tube_NN containing_VBG 3_CD ml_NN of_IN Complete_JJ Mini_NNP protease_NN
          inhibitor_NN cocktail_NN homogenization_NN buffer_NN (_( Roche_NNP ,_,
          Indianapolis_NNP ,_, IN_IN ,_, USA_NNP )_) ._. Synovial_NNP tissue_NN homogenization_NN
          was_VBD completed_VBN on_IN ice_NN using_VBG a_DT motorized_VBN homogenizer_NN ,_,
          followed_VBN by_IN sonication_NN for_IN 30_CD seconds_NNS ._. Homogenates_NNP were_VBD
          centrifuged_JJ at_IN 2000_CD ×_NN g_SYM for_IN 10_CD minutes_NNS ,_, filtered_VBN through_IN a_DT
          0_CD ._. 45_CD μm_NN pore_NN size_NN filter_NN (_( Bedpore_NNP ,_, Bedford_NNP ,_, MA_NNP ,_, USA_NNP )_) and_CC
          stored_VBD at_IN -_: 80_CD °_NN C_NNP until_IN use_NN ._. Complete_JJ Mini_NNP protease_NN
          inhibitor_NN cocktail_NN (_( 1_CD ml_NN )_) was_VBD added_VBN to_TO one_CD million_CD RA_NNP
          fibroblasts_NNS and_CC HMVECs_NNP for_IN lysis_NNS ._. The_DT concentration_NN of_IN
          protein_NN in_IN each_DT synovial_NN tissue_NN and_CC cell_NN lysate_NN was_VBD
          determined_VBN using_VBG a_DT bicinchoninic_JJ acid_NN assay_NN (_( Pierce_NNP ,_,
          Rockford_NNP ,_, IL_NNP ,_, USA_NNP )_) ,_, using_VBG BSA_NNP as_IN the_DT standard_NN ._. Protein_NNP
          extracts_NNS (_( 25_CD μg_NN )_) were_VBD mixed_VBN with_IN an_DT equal_JJ volume_NN of_IN 2_CD ×_NN
          Laemmli_NNP 's_POS sample_NN buffer_NN ._. Equal_NNP amounts_NNS of_IN each_DT sample_NN
          were_VBD loaded_VBN and_CC run_VB on_IN a_DT 10_CD %_NN SDS-PAGE_NNP gel_NN and_CC transferred_VBN
          to_TO nitrocellulose_NN membranes_NNS using_VBG a_DT semi-dry_JJ
          transblotting_VBG apparatus_NN (_( Bio-_NNP Rad_NNP ,_, Richmond_NNP ,_, CA_NNP ,_, USA_NNP )_) ._.
          Nitrocellulose_NNP membranes_NNS were_VBD blocked_VBN with_IN 5_CD %_NN nonfat_JJ milk_NN
          in_IN Tris-buffered_NNP saline_NN Tween_NNP (_( 20_CD mM_NN Tris_NNP ,_, 137_CD mM_NN NaCl_NNP ,_,
          pH_NN 7_CD ._. 6_CD ,_, with_IN 0_CD ._. 1_CD %_NN Tween_NNP 20_CD )_) for_IN 60_CD minutes_NNS at_IN room_NN
          temperature_NN ._. Blots_NNP were_VBD incubated_JJ overnight_JJ with_IN
          anti-_NN Tie_NNP 1_CD and_CC anti-_NN Tie_NNP 2_CD antibodies_NNS (_( R_NN &_CC D_NNP Systems_NNPS )_) at_IN
          1_CD :_: 5000_CD ,_, in_IN Tris-buffered_NNP saline_NN Tween_NNP containing_VBG 5_CD %_NN
          nonfat_JJ milk_NN ._. Blots_NNP were_VBD washed_VBN three_CD times_NNS and_CC then_RB
          incubated_JJ in_IN horseradish-peroxidase-conjugated_JJ antibody_NN
          (_( 1_CD :_: 10_CD ,_, 000_CD dilution_NN )_) for_IN one_CD hour_NN at_IN room_NN temperature_NN ._. All_DT
          blots_NNS were_VBD developed_VBN using_VBG the_DT enhanced_JJ chemiluminesence_NN
          reagents_NNS (_( Amersham_NNP ,_, Piscataway_NNP ,_, NJ_NNP ,_, USA_NNP )_) as_IN per_IN the_DT
          manufacturer_NN 's_POS instructions_NNS ._.
        
      
    
  
